Inosiplex enhances the growth of Epstein-Barr nuclear antigen-positive B-cells from patients with rheumatoid arthritis and infectious mononucleosis
- 1 January 1988
- journal article
- research article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 10 (4) , 439-443
- https://doi.org/10.1016/0192-0561(88)90131-2
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Isoprinosine effects on interleukin-1 production in acquired immune deficiency syndrome (AIDS)International Journal of Immunopharmacology, 1986
- A double-blind clinical trial of the effects of inosine pranobex in immunodepressed patients with prolonged generalized lymphadenopathyClinical Immunology and Immunopathology, 1986
- Partial restoration of impaired interleukin-2 production and Tac antigen (putative interleukin-2 receptor) expression in patients with acquired immune deficiency syndrome by isoprinosine treatment in vitro.Journal of Clinical Investigation, 1985
- In vitro restoration of immune responses in aging humans by isoprinosineInternational Journal of Immunopharmacology, 1985
- Isoprinosine enhances the activation of sensitized lymphocytes by Epstein-Barr virus antigensInternational Journal of Immunopharmacology, 1985
- Abnormally elevated frequency of Epstein-Barr virus-infected B cells in the blood of patients with rheumatoid arthritis.Journal of Clinical Investigation, 1984
- Human B Cell Activation, Proliferation and DifferentiationImmunological Reviews, 1984
- Restoration of immune responses of aging hamsters by treatment with isoprinosine.Journal of Clinical Investigation, 1983
- RHEUMATOID ARTHRITIS: A DISEASE OF T-LYMPHOCYTE/MACROPHAGE IMMUNOREGULATIONThe Lancet, 1981
- Role of Polyclonal Activation in Specific Immune ResponsesScandinavian Journal of Immunology, 1980